Lanzamiento Enero 2027

Ensayo controlado aleatorizado2024Financiado por la industriaAlimentación controlada

Financiado en parte por Cotton Incorporated, Georgia Cotton Commission, Cotton Inc

Eight weeks of daily cottonseed oil intake attenuates postprandial angiopoietin-like proteins 3 and 4 responses compared to olive oil in adults with hypercholesterolemia: A secondary analysis of a randomized clinical trial

Prater MC, Scheurell AR, Paton CM, Cooper JA

Nutrition research (New York, N.Y.) · 2 citas

Etiquetas de revisión

Alimentación controladaFinanciado por la industria

Datos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento
Consumo medido con
Comida provista por los investigadores

Quién lo pagó

Financiación
Financiado por la industria
Grupo de la industria
Cotton Incorporated
Grupo de la industria
Georgia Cotton Commission
Grupo de la industria
Cotton Inc

Según 3 financiadores declarados.

Publicación

Publicado
2024-01-12 · Nutr Res · vol. 123 · págs. 88–100
Editorial
Elsevier BV
Citado
2 citas · más que el 67% de estudios similares · 0.5× el promedio de su campo
Referencias
48 trabajos
Acceso
De pago
Áreas de investigación
Lipid metabolism and disorders · Fatty Acid Research and Health · Cholesterol and Lipid Metabolism
Palabras clave
cottonseed oil, olive oil, angiopoietin-like proteins, ANGPTL3, ANGPTL4, ANGPTL8, hypercholesterolemia, postprandial lipemia, dietary fat, saturated fat, lipid metabolism, triglycerides, high-cholesterol diet, postprandial lipoproteins
MeSH
humans, hypercholesterolemia, peptide hormones, dietary fats, cottonseed oil, triglycerides, plant oils, cross-over studies, single-blind method, postprandial period, adult, olive oil, angiopoietin-like protein 3, angiopoietin-like protein 8

4 autores

  • Mary Catherine Prater🇺🇸University of Georgia
  • Alexis R. Scheurell🇺🇸University of Georgia
  • Chad Michael Paton🇺🇸University of Georgia
  • Jamie A. Cooper🇺🇸 · autor de correspondenciaUniversity of Georgia

Resumen

El texto original del estudio, en el idioma en que se publicó.

Angiopoietin-like proteins (ANGPTLs) -3, -4, and -8 are regulators of lipid metabolism and have been shown to respond to changes in dietary fats. It is unknown how ANGPTLs respond to cottonseed oil (CSO) and olive oil (OO) consumption in a population with hypercholesterolemia. The purpose of this study was to determine the impact of CSO vs. OO consumption on fasting and postprandial ANGPTL responses in adults with hypercholesterolemia. We hypothesized that CSO would have lower fasting and postprandial ANGPTL responses compared with OO. Forty-two adults with high cholesterol completed a single-blind, randomized trial comparing CSO (n = 21) vs. OO (n = 21) diet enrichment. An 8-week partial outpatient feeding intervention provided ∼60% of the volunteers' total energy expenditure (∼30% of total energy expenditure as CSO or OO). The remaining 40% was not controlled. Fasting blood draws were taken at pre-, mid-, and postintervention visits. Volunteers consumed a high saturated fat meal followed by 5 hours of blood draws pre- and postvisits. Fasting ANGPTL3 had a marginally significant treatment by visit interaction (P = .06) showing an increase from pre- to postintervention in CSO vs. OO (CSO: 385.1 ± 27.7 to 440.3 ± 33.9 ng/mL; OO: 468.2 ± 38.3 to 449.2 ± 49.5 ng/mL). Both postprandial ANGPTL3 (P = .02) and ANGPTL4 (P < .01) had treatment by visit interactions suggesting increases from pre- to postintervention in OO vs. CSO with no differences between groups in ANGPTL8. These data show a worsening (increase) of postprandial ANGPTLs after the OO, but not CSO, intervention. This aligns with previously reported data in which postprandial triglycerides were protected from increases compared with OO. ANGPTLs may mediate protective effects of CSO consumption on lipid control. This trial was registered at clinicaltrials.gov (NCT04397055).

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.